Fourth year in the 'Pharma Fast 50' for Oxford PharmaGenesis
For the fourth year in a row, Oxford PharmaGenesis has been listed in the Alantra Pharma Fast 50 as one of the UK’s fastest-growing, privately owned pharmaceutical businesses.
Featured
24 January 2024
ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
All
- All
- News
- Articles
- Events
Reporting from the Women in Data Science Conference
Today I’m attending the online Women in Data Science Worldwide Conference, along with tens of thousands of professionals, speakers, ambassadors and thought leaders reports Hollie Rawlings (Data Analyst – Informatics and Data Science).
Time to Talk Day
With the challenges presented over the past year, keeping in touch has been more important than ever. The COVID-19 pandemic has affected us all in different ways, and a short conversation with a colleague, friend or family member about mental health has the power to make a big difference.
Oxford PharmaGenesis – MAD appeal
Making a difference to our communities across the globe As our employees’ fundraising was affected by the COVID-19 pandemic, our company Charity Team wanted to use the charity budget to maximize our support for hard-pressed charities, while giving our employees the opportunity to give back during lockdown. Therefore, we launched the ‘Make a Difference’ (MAD)…
Highlights from Virtual ISPOR Europe 2020
16–19 November The ISPOR Europe 2020 conference was the society’s first ever virtual meeting. It brought together a vibrant community of experts and thought leaders to help to shape the future of health economics and outcomes research (HEOR). The theme of the 2020 meeting was Improving Health: Establishing Incentives and Sharing Value, and it sought…
